BAL PHARMA
Back to Income Statement
|
BAL PHARMA Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹4.53 | ₹4.68 | ₹1.64 | ₹3.79 | ₹3.20 |
What is the latest Earnings Per Share (EPS) of BAL PHARMA ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹4.53 |
| Mar2024 | ₹4.68 |
| Mar2023 | ₹1.64 |
| Mar2022 | ₹3.79 |
| Mar2021 | ₹3.20 |
How is Earnings Per Share (EPS) of BAL PHARMA Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.53 | -3.21 | |
| Mar2024 | ₹4.68 | 185.37 | |
| Mar2023 | ₹1.64 | -56.73 | |
| Mar2022 | ₹3.79 | 18.44 | |
| Mar2021 | ₹3.20 | - | |
Compare Earnings Per Share (EPS) of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹139.2 Cr | 12.5% | -1.3% | -12.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,458.0 Cr | 0.7% | 8.1% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,383.0 Cr | 7% | 10.2% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,829.0 Cr | 2.5% | 11.3% | 49.6% | Stock Analytics | |
| CIPLA | ₹116,164.0 Cr | -0.3% | 4.1% | -3.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,648.0 Cr | -3.2% | -3.9% | -3% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | 12.5% |
-1.3% |
-12.7% |
| SENSEX | 0.9% |
2.2% |
-7.5% |
You may also like the below Video Courses